Latest News

• Chengdu Locks Down 21.2 Million as Chinese Cities Battle COVID The Chinese city of Chengdu will conduct mass COVID-19 testing from Thursday to Sunday, its city government said on Thursday.
  Reuters Health Information, September 01, 2022
• After Long Drought, China Plots Big Water Infrastructure Push Chinese provinces are planning to spend billions of dollars on new water infrastructure as they try to fend off the growing impact of extreme weather on agriculture and hydropower.
  Reuters Health Information, September 01, 2022
• Acute Myocarditis a Possible Complication of Monkeypox A 31-year-old man with confirmed monkeypox developed acute myocarditis roughly 1 week after eruption of the characteristic skin lesions of the disease.
  Medscape Medical News, September 02, 2022
• Hong Kong Leader Proposes 'Reverse Quarantine' for China Travel Hong Kong hopes to introduce "reverse quarantine" for people going to mainland China as the financial hub seeks to open up to the neighboring technology city of Shenzhen.
  Reuters Health Information, September 01, 2022
• Hospitalized COVID-19 Patients With GI Symptoms Have Worse Outcomes Patients with GI symptoms were also more likely to have higher Charlson Comorbidity Index scores and be 50 years and older.
  MDedge News, September 02, 2022
• Hepatitis C Meds Linked to Improved PTSD Symptoms The combination of the antiviral medications glecaprevir and pibrentasvir may improve posttraumatic stress disorder symptoms in patients with comorbid hepatitis C, new research suggests.
  Medscape Medical News, September 02, 2022
• Living-Donor Liver Transplant Tied to Substantial Survival Benefit The benefit was even significant at Model for End-Stage Liver Disease-Sodium scores as low as 11.
  MDedge News, September 02, 2022
• BMI, Sex Linked to Roux Stasis Syndrome After Gastrectomy The investigation identifies patients who need preventive measures. The study was published as a preprint and has not yet been peer reviewed.
  First Look, September 02, 2022
• India Develops Its First Cervical Cancer Vaccine The Serum Institute of India, the world's biggest vaccine maker, has developed the country's first cervical cancer shot that will hit the market soon, the company and the government said.
  Reuters Health Information, September 01, 2022
• EU Regulator Backs Two Omicron-Adapted COVID Boosters The EU's drug regulator on Thursday backed two separate COVID-19 vaccine boosters updated to target the Omicron variant and developed by rivals Moderna and Pfizer-BioNTech.
  Reuters Health Information, September 01, 2022
• WHO Provides Insulin Pens for Diabetes to Ukraine Hospitals The World Health Organization is delivering insulin pens to hospitals throughout Ukraine for those with diabetes as Russia continues its invasion.
  Medscape Medical News, September 02, 2022
• J&J to Pay $40.5 Million to Settle New Hampshire Opioid Lawsuit Johnson & Johnson has agreed to pay $40.5 million to settle New Hampshire's claims over the company's role in the US opioid epidemic, averting a trial.
  Reuters Health Information, September 01, 2022
• Symptoms Predict Therapy Failure, Death in Oropharyngeal Cancer Specifically, shortness-of-breath and dysphagia can help guide surveillance after radiotherapy. The study was published as a preprint and has not yet been peer reviewed.
  First Look, September 02, 2022
• Germany to Start Omicron-Adapted COVID Vaccinations Next Week Germany can next week start using COVID-19 vaccines that have been adapted for the Omicron variant and got approval for use in the European Union, Health Minister Karl Lauterbach said.
  Reuters Health Information, September 01, 2022
• Canada Authorizes Its First Omicron-Adapted Vaccine for Adults Canada on Thursday authorized Moderna Inc's bivalent COVID-19 shots for adults, adding the first Omicron-adapted vaccine to its arsenal as the fall and winter approach.
  Reuters Health Information, September 01, 2022
• EU Regulator Backs Use of Novavax COVID Shot as a Booster The European Medicines Agency on Thursday backed the use of Novavax's COVID-19 shot as a booster for adults, ahead of an anticipated rise in infections this winter.
  Reuters Health Information, September 01, 2022
• Philips Subsidiary to Pay Over $24 Mln for Alleged False Claims A subsidiary of Dutch medical device maker Philips has agreed to pay over $24 million to resolve alleged false claims over respiratory-related medical equipment, the Justice Department announced.
  Reuters Health Information, September 01, 2022
• NCI Postdoc Faked Data, Says Federal Watchdog The finding from the ORI comes more than a year after PLOS Biology retracted a 2016 paper and noted that the NIH had found that the postdoc committed misconduct and faked data in two figures.
  Retraction Watch, September 02, 2022
• Socioeconomic Position Linked With Health Status, Survival Low socioeconomic status is associated with a higher risk for at least one chronic condition as well as a shorter survival rate independent of chronic conditions, new data suggest.
  Medscape Medical News, September 02, 2022
• Exercise May Counteract Genetics for Gestational Diabetes Researchers concluded that physical activity early in pregnancy is associated with reduced risk for gestational diabetes and may help women who are at high risk.
  MDedge News, September 02, 2022